Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia

Faryal Khamis*, Hanan Al Naabi, Adil Al Lawati, Zaiyana Ambusaidi, Mariam Al Sharji, Umkulthum Al Barwani, Nenad Pandak, Zakariya Al Balushi, Maher Al Bahrani, Issa Al Salami, Ibrahim Al-Zakwani

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

66 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia'. Together they form a unique fingerprint.

Medicine and Dentistry

Agricultural and Biological Sciences